Congress communication

Congress communication RDF

páginas:

TITULO TRATAMIENTO DEL FRACASO DE NEUROADAPTACIÓN A LENTE MULTIFOCAL MEDIANTE INTERCAMBIO POR OTRA LENTE DE DIFERENTE DISEÑO ÓPTICO Conference Paper 2019
TITULO WEBINAR: Corneal approach to presbyopia treatment - Multifocal laser presbyopic correction Conference Paper 2023
TITULO: DIAGNOSIS AND TREATMENT OUTCOMES OF FUNGAL KERATITIS. Conference Poster 2018
TÍTULO: Diagnóstico y aproximación terapéutica del Queratocono Conference Paper 2023
TITULO: DMEK in especially difficult cases: how to do it successfully? Conference Paper 2023
TITULO: EDOF IOLs: how to understand and select them Conference Paper 2023
TITULO: Morphovolumetric analysis and classification of Keratoconus based on visual function: an essential tool in the analysis of the outcomes of CXL Conference Paper 2023
Título: PROTON TRANSFER FROM LIGANDS IS REQUIRED TO ACTIVATE EXTRANUCLEAR-INITIATED ESTROGEN RECEPTOR SIGNALING Conference Paper 2024
TITULO: Regeneration of corneal stroma: keratoconus treatment with stem cells Conference Paper 2023
TÍTULO: Técnicas de explante e intercambio de lentes pseudofáquicas de cámara posterior. Conference Paper 2023
To walk or not to walk: insights from a qualitative description study with women suffering from fibromyalgia. Conference Paper 2016
To what extent does past performance influence network formation in clusters? Evidence from the Valencia region Conference Paper 2013
TOCILIZUMAB EN 22 PACIENTES CON ARTERITIS DE CE¿LULAS GIGANTES Conference Poster 2015
TOCILIZUMAB EN ARTERITIS DE CÉLULAS GIGANTES DE RECIENTE DIAGNÓSTICO VERSUS REFRACTARIA/RECURRENTE. ESTUDIO MULTICÉNTRICO DE 471 PACIENTES DE LA PRÁCTICA CLÍNICA Conference Poster 2022
TOCILIZUMAB EN ARTERITIS DE TAKAYASU EN CAUCÁSICOS: ESTUDIO MULTICÉNTRICO DE 54 PACIENTES Conference Poster 2021
TOCILIZUMAB EN ARTERITIS DE TAKAYASU. ESTUDIO NACIONAL MULTICÉNTRICO DE 53 PACIENTES EN PRÁCTICA CLÍNICA Conference Paper 2020
TOCILIZUMAB EN LA AFECTACIÓN VISUAL DE LA ARTERITIS DE CÉLULAS GIGANTES. ESTUDIO MULTICÉNTRICO DE 471 PACIENTES DE PRÁCTICA CLÍNICA Conference Poster 2021
TOCILIZUMAB EN LA ARTERITIS DE CÉLULAS GIGANTES CON AFECTACIÓN DE VASO GRANDE Y EN LA ARTERITIS DE TAKAYASU. ESTUDIO OBSERVACIONAL MULTICÉNTRICO COMPARATIVO Conference Poster 2022
TOCILIZUMAB EN LA PRA¿CTICA CLI¿NICA EN 31 PACIENTES CON ARTERITIS DE CE¿LULAS GIGANTES. EVOLUCIO¿N A CORTO Y LARGO PLAZO Conference Poster 2017
TOCILIZUMAB EN LOS FENOTIPOS CRANEAL Y EXTRACRANEAL DE LA ARTERITIS DE CÉLULAS GIGANTES. ESTUDIO MULTICÉNTRICO DE 471 PACIENTES Conference Paper 2021
TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS Conference Poster 2021
Tocilizumab in Caucasian Patients with Takayasu Arteritis: Multicenter Study of 54 Patients Conference Poster 2021
TOCILIZUMAB IN CRANIAL AND EXTRACRANIAL REFRACTORY GIANT CELL ARTERITIS: A MULTICENTER STUDY OF 312 CASES Conference Paper 2021
Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 134 Patients of Clinical Practice Conference Poster 2018
Tocilizumab in giant cell arteritis. national multicenter study of 134 patients of clinical practice Conference Poster 2018
Tocilizumab in Giant Cell Arteritis: Route of Administration: Intravenous or Subcutaneous Conference Poster 2019
Tocilizumab in Giant Cell Arteritis: The Safest and Most Effective Initial Dose of Prednisone Conference Poster 2019
Tocilizumab in Giant Cell Arteritis:Multicenter Open-Label Study of 22 Patients. Conference Poster 2014
Tocilizumab in Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: Multicentric Observational Comparative Study Conference Poster 2022
TOCILIZUMAB IN LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: MULTICENTRIC OBSERVATIONAL COMPARATIVE STUDY Conference Poster 2022

páginas: